» Articles » PMID: 26836195

Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2016 Feb 3
PMID 26836195
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hemin is known to induce endocytosis of prion-protein (PrP(C)) from the neuronal plasma membrane, potentially limiting propagation of the disease causing PrP-scrapie (PrP(Sc)) isoform. Hemin is therefore an attractive disease-modifying option for sporadic Creutzfeldt-Jakob disease (sCJD), a human prion disorder with no effective treatment. The hemin-PrP(C) interaction is also of interest in cerebral-hemorrhage (CH), a condition where potentially toxic hemin molecules come in contact with neuronal PrP(C). Interestingly, PrP(C) is upregulated in penumbric neurons surrounding CH and is known to confer neuroprotection in a dose-dependent manner. The underlying mechanism, however, is not clear. Here, we report that hemin binds PrP(C) on diverse cell lines, resulting in its aggregation or degradation in a cell-type specific manner. Surprisingly, the hemin-PrP(C) interaction upregulates Hb synthesis in hematopoietic cells, a response reversed by deleting the hemin-binding octa-peptide repeat region of PrP(C). A similar response is noted in brain organotypic cultures where exposure to hemin induces significantly more α-globin in wild-type (PrP(+/+)) relative to PrP-knock-out (PrP(-/-)) samples. Furthermore, red blood cells and brain tissue from PrP(-/-) mice show significantly less α-globin relative to PrP(+/+) controls, indicating a positive effect of PrP(C) on Hb synthesis under physiological conditions as well. Surprisingly, levels of α-globin are significantly higher in sCJD brain tissue relative to controls, suggesting compensatory upregulation of Hb synthesis by surviving neurons or misregulation in diseased brains. These observations reveal a unique function of PrP(C) that is likely to impact the therapeutic management of CH and sCJD.

Citing Articles

Erythrocyte Indices in Creutzfeldt-Jakob Disease Predict Survival Time.

Kong Y, Chen Z, Zhang J, Wu L Front Neurol. 2022; 13:839081.

PMID: 35237232 PMC: 8884143. DOI: 10.3389/fneur.2022.839081.


Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Loh D, Reiter R Molecules. 2022; 27(3).

PMID: 35163973 PMC: 8839844. DOI: 10.3390/molecules27030705.


Interaction between Hemin and Prion Peptides: Binding, Oxidative Reactivity and Aggregation.

DellAcqua S, Massardi E, Monzani E, Di Natale G, Rizzarelli E, Casella L Int J Mol Sci. 2020; 21(20).

PMID: 33066163 PMC: 7589926. DOI: 10.3390/ijms21207553.


Pervasive Genomic Damage in Experimental Intracerebral Hemorrhage: Therapeutic Potential of a Mechanistic-Based Carbon Nanoparticle.

Dharmalingam P, Talakatta G, Mitra J, Wang H, Derry P, Nilewski L ACS Nano. 2020; 14(3):2827-2846.

PMID: 32049495 PMC: 7850811. DOI: 10.1021/acsnano.9b05821.


MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats.

Ouyang Y, Li D, Wang H, Wan Z, Luo Q, Zhong Y Aging Cell. 2019; 18(6):e13022.

PMID: 31400088 PMC: 6826124. DOI: 10.1111/acel.13022.


References
1.
Head M, Ironside J . Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol. 2012; 38(4):296-310. DOI: 10.1111/j.1365-2990.2012.01265.x. View

2.
Schaer D, Buehler P, Alayash A, Belcher J, Vercellotti G . Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2012; 121(8):1276-84. PMC: 3578950. DOI: 10.1182/blood-2012-11-451229. View

3.
He Y, Hua Y, Liu W, Hu H, Keep R, Xi G . Effects of cerebral ischemia on neuronal hemoglobin. J Cereb Blood Flow Metab. 2008; 29(3):596-605. PMC: 2683405. DOI: 10.1038/jcbfm.2008.145. View

4.
Kim H, Whittle S, Lee S, Chu H, Zhang S, Wei Z . Brain immune cell composition and functional outcome after cerebral ischemia: comparison of two mouse strains. Front Cell Neurosci. 2014; 8:365. PMC: 4237143. DOI: 10.3389/fncel.2014.00365. View

5.
Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H, DeArmond S . Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992; 356(6370):577-82. DOI: 10.1038/356577a0. View